Results 171 to 180 of about 3,002 (191)

Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain

European Journal of Pharmacology, 1979
M Quik, Leslie L Iversen, Maryka Quik
exaly  

3-(2'-[ 18 F]Fluoroethyl)Spiperone: In vivo Biochemical and Kinetic Characterization in Rodents, Nonhuman Primates, and Humans

Journal of Cerebral Blood Flow and Metabolism, 1989
John C Mazziotta, Nagichettiar Satyamurthy, Robert F Ackermann   +2 more
exaly  

USE OF SPIPERONE OR SPIPERONE DERIVATIVES AS IMMUNOSUPPRESSANT AGENTS.

1994
SHARPE RICHARD J, ARNDT KENNETH A, GALLI STEPHEN J, MELTZER PETER C, RAZDAN RAJ K, SARD HOWARD P   +5 more
openaire   +2 more sources

Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone

European Journal of Pharmacology, 1982
S R Nahorski
exaly  

Binding of 3H-spiperone to human lymphocytes: A biological marker in schizophrenia?

Psychiatry Research, 1985
Brigitta Bondy, Brigitta Bondy, M Ackenheil   +2 more
exaly  

Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus

European Journal of Pharmacology, 1988
M F Piercey, Montford F Piercey
exaly  

In vivo [3H]spiperone binding to the rat hippocampal formation: Involvement of dopamine receptors

European Journal of Pharmacology, 1980
Helmut Bittiger, J Krauss
exaly  

Spiperone derivatives and methods of treating disorders

2010
GUGGINO WILLIAM B, SCHWIEBERT ERIK M, LIANG LIHUA   +2 more
openaire   +3 more sources

Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations

European Journal of Pharmacology, 1984
Philip Beart, D J de Vries
exaly  

Lack of stimulation by high amphetamine doses following a low dose of spiperone

European Journal of Pharmacology, 1977
Robert Kerns
exaly